Latest 22 News in the Life Sciences Industry
PR Newswire Association LLC.
AbbVie Employees Across Asia Unite Through Week of Possibilities by Serving and Supporting Communities
13 Jul 2026
GlobeNewswire
Boehringer Ingelheim accelerates precision oncology research with initiation of three Phase III trials in hard-to-treat cancers
22 Jun 2026
GlobeNewswire
New European initiative to accelerate drug discovery for cardiometabolic diseases
19 Jun 2026
GlobeNewswire
New analyses from FIBRONEER™ trials suggest survival benefit with nerandomilast in IPF and PPF
18 Jun 2026
GlobeNewswire
Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK
11 Jun 2026
GlobeNewswire
Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity
07 Jun 2026
GlobeNewswire
Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care
03 Jun 2026
PR Newswire Association LLC.
Wegovy® (semaglutide) label updated in Singapore with higher dose supported by STEP UP evidence
08 Jul 2026
PR Newswire Association LLC.
For the Reasons that Matter: A Multi-Spotlight Campaign Puts Adult Respiratory Health in Focus
07 May 2026
PR Newswire Association LLC.
For the Reasons that Matter: A First‑of‑Its‑Kind Multi-Country Campaign Spotlights Adult Respiratory Health
30 Apr 2026
Upcoming Events All Events
- July 2026
- Taipei: BIO Asia-Taiwan
- August 2026
- Online: Biotechgate Digital Partnering August 2026
- September 2026
- Marina Bay Sands: Asia Bio Partnering Forum